AgencyBloc Named Bronze Stevie Award® Winner in 2026 American Business Awards® Certara Appoints Drayton T. Virkler as Chief Commercial Officer
Experienced commercial leader brings 20 years of experience in pharma PRINCETON, N.J., Oct. 05, 2021…
Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings
– Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS…
VYNE Therapeutics Announces its China Partner’s Enrollment of First Patient in Phase 3 Study of AMZEEQ® in Patients with Moderate to Severe Acne
BRIDGEWATER, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential Anti-Anxiety Activity via Peripheral Nasal Neurons without Entry into the Brain
Preclinical study of intranasal radiolabeled PH94B in laboratory rats further differentiates PH94B’s mechanism of action…
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
WATERTOWN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced…
VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States
Amos Ron to Retire as CFO and Will Continue to Serve as Corporate Secretary, Advisor…
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from Pooled Donor Cells
Nes-Ziona, Israel, Oct. 05, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial
– UDENYCA® On-Body Injector (OBI) Achieved Both Pharmacokinetic and Pharmacodynamic Bioequivalence in Randomized Clinical Trial…
Akero Therapeutics to Present at the H.C. Wainwright 5th Annual NASH Investor Conference
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…
Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer
Industry veteran with decades of experience in company formation, scientific research, and drug development to…
Quotient Limited Announces Appointment of Chief Commercial Officer
JERSEY, Channel Islands, Oct. 05, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
Statera Biopharma Announces CEO Mike Handley to Speak During Virtual B & T Cell-Mediated Autoimmune Disease Drug Development Summit
FORT COLLINS, Colo., Oct. 05, 2021 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (Nasdaq: STAB), a…
Nephros to Present at the LD Micro Main Event
SOUTH ORANGE, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading…
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson
Research to take place at Johns Hopkins, New York University and University of Alabama Birmingham…
Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
Humacyte Leadership to Present at Seven Scientific and Industry Events in October
DURHAM, N.C., Oct. 05, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations
WALTHAM, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical…
Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors
SOMERVILLE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
Participating Investors include Viva BioInnovator, Eli Lilly and Company, Opaleye Management, Orange Grove Bio and…
Baudax Bio to Present at the NobleCon Pain Management Investor Forum
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…